Global CAR T-cell Therapy Drug Market Research Report 2024, Forecast to 2032

October 2024 | 117 pages | ID: G5EFCF0A091BEN
Bosson Research

Abstracts

Report Overview

Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer

The global CAR T-cell Therapy Drug market size was estimated at USD 2805.80 million in 2023 and is projected to reach USD 29548.75 million by 2032, exhibiting a CAGR of 29.90% during the forecast period.

North America CAR T-cell Therapy Drug market size was estimated at USD 1153.88 million in 2023, at a CAGR of 25.63% during the forecast period of 2024 through 2032.

This report provides a deep insight into the global CAR T-cell Therapy Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global CAR T-cell Therapy Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the CAR T-cell Therapy Drug market in any manner.

Global CAR T-cell Therapy Drug Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Novartis

Gilead Sciences

Bristol-Myers Squibb

J & J

JW Therapeutics

FOSUNKite

Market Segmentation (by Type)

CD19-targeted

BCMA-targeted

Market Segmentation (by Application)

Lymphoma

Multiple Myeloma

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the CAR T-cell Therapy Drug Market
• Overview of the regional outlook of the CAR T-cell Therapy Drug Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the CAR T-cell Therapy Drug Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of CAR T-cell Therapy Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.

Chapter 13 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of CAR T-cell Therapy Drug
1.2 Key Market Segments
  1.2.1 CAR T-cell Therapy Drug Segment by Type
  1.2.2 CAR T-cell Therapy Drug Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 CAR T-CELL THERAPY DRUG MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global CAR T-cell Therapy Drug Market Size (M USD) Estimates and Forecasts (2019-2032)
  2.1.2 Global CAR T-cell Therapy Drug Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 CAR T-CELL THERAPY DRUG MARKET COMPETITIVE LANDSCAPE

3.1 Global CAR T-cell Therapy Drug Sales by Manufacturers (2019-2024)
3.2 Global CAR T-cell Therapy Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 CAR T-cell Therapy Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global CAR T-cell Therapy Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers CAR T-cell Therapy Drug Sales Sites, Area Served, Product Type
3.6 CAR T-cell Therapy Drug Market Competitive Situation and Trends
  3.6.1 CAR T-cell Therapy Drug Market Concentration Rate
  3.6.2 Global 5 and 10 Largest CAR T-cell Therapy Drug Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 CAR T-CELL THERAPY DRUG INDUSTRY CHAIN ANALYSIS

4.1 CAR T-cell Therapy Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF CAR T-CELL THERAPY DRUG MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 CAR T-CELL THERAPY DRUG MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global CAR T-cell Therapy Drug Sales Market Share by Type (2019-2024)
6.3 Global CAR T-cell Therapy Drug Market Size Market Share by Type (2019-2024)
6.4 Global CAR T-cell Therapy Drug Price by Type (2019-2024)

7 CAR T-CELL THERAPY DRUG MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global CAR T-cell Therapy Drug Market Sales by Application (2019-2024)
7.3 Global CAR T-cell Therapy Drug Market Size (M USD) by Application (2019-2024)
7.4 Global CAR T-cell Therapy Drug Sales Growth Rate by Application (2019-2024)

8 CAR T-CELL THERAPY DRUG MARKET CONSUMPTION BY REGION

8.1 Global CAR T-cell Therapy Drug Sales by Region
  8.1.1 Global CAR T-cell Therapy Drug Sales by Region
  8.1.2 Global CAR T-cell Therapy Drug Sales Market Share by Region
8.2 North America
  8.2.1 North America CAR T-cell Therapy Drug Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe CAR T-cell Therapy Drug Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific CAR T-cell Therapy Drug Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America CAR T-cell Therapy Drug Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa CAR T-cell Therapy Drug Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 CAR T-CELL THERAPY DRUG MARKET PRODUCTION BY REGION

9.1 Global Production of CAR T-cell Therapy Drug by Region (2019-2024)
9.2 Global CAR T-cell Therapy Drug Revenue Market Share by Region (2019-2024)
9.3 Global CAR T-cell Therapy Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America CAR T-cell Therapy Drug Production
  9.4.1 North America CAR T-cell Therapy Drug Production Growth Rate (2019-2024)
  9.4.2 North America CAR T-cell Therapy Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe CAR T-cell Therapy Drug Production
  9.5.1 Europe CAR T-cell Therapy Drug Production Growth Rate (2019-2024)
  9.5.2 Europe CAR T-cell Therapy Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan CAR T-cell Therapy Drug Production (2019-2024)
  9.6.1 Japan CAR T-cell Therapy Drug Production Growth Rate (2019-2024)
  9.6.2 Japan CAR T-cell Therapy Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China CAR T-cell Therapy Drug Production (2019-2024)
  9.7.1 China CAR T-cell Therapy Drug Production Growth Rate (2019-2024)
  9.7.2 China CAR T-cell Therapy Drug Production, Revenue, Price and Gross Margin (2019-2024)

10 KEY COMPANIES PROFILE

10.1 Novartis
  10.1.1 Novartis CAR T-cell Therapy Drug Basic Information
  10.1.2 Novartis CAR T-cell Therapy Drug Product Overview
  10.1.3 Novartis CAR T-cell Therapy Drug Product Market Performance
  10.1.4 Novartis Business Overview
  10.1.5 Novartis CAR T-cell Therapy Drug SWOT Analysis
  10.1.6 Novartis Recent Developments
10.2 Gilead Sciences
  10.2.1 Gilead Sciences CAR T-cell Therapy Drug Basic Information
  10.2.2 Gilead Sciences CAR T-cell Therapy Drug Product Overview
  10.2.3 Gilead Sciences CAR T-cell Therapy Drug Product Market Performance
  10.2.4 Gilead Sciences Business Overview
  10.2.5 Gilead Sciences CAR T-cell Therapy Drug SWOT Analysis
  10.2.6 Gilead Sciences Recent Developments
10.3 Bristol-Myers Squibb
  10.3.1 Bristol-Myers Squibb CAR T-cell Therapy Drug Basic Information
  10.3.2 Bristol-Myers Squibb CAR T-cell Therapy Drug Product Overview
  10.3.3 Bristol-Myers Squibb CAR T-cell Therapy Drug Product Market Performance
  10.3.4 Bristol-Myers Squibb CAR T-cell Therapy Drug SWOT Analysis
  10.3.5 Bristol-Myers Squibb Business Overview
  10.3.6 Bristol-Myers Squibb Recent Developments
10.4 J and J
  10.4.1 J and J CAR T-cell Therapy Drug Basic Information
  10.4.2 J and J CAR T-cell Therapy Drug Product Overview
  10.4.3 J and J CAR T-cell Therapy Drug Product Market Performance
  10.4.4 J and J Business Overview
  10.4.5 J and J Recent Developments
10.5 JW Therapeutics
  10.5.1 JW Therapeutics CAR T-cell Therapy Drug Basic Information
  10.5.2 JW Therapeutics CAR T-cell Therapy Drug Product Overview
  10.5.3 JW Therapeutics CAR T-cell Therapy Drug Product Market Performance
  10.5.4 JW Therapeutics Business Overview
  10.5.5 JW Therapeutics Recent Developments
10.6 FOSUNKite
  10.6.1 FOSUNKite CAR T-cell Therapy Drug Basic Information
  10.6.2 FOSUNKite CAR T-cell Therapy Drug Product Overview
  10.6.3 FOSUNKite CAR T-cell Therapy Drug Product Market Performance
  10.6.4 FOSUNKite Business Overview
  10.6.5 FOSUNKite Recent Developments

11 CAR T-CELL THERAPY DRUG MARKET FORECAST BY REGION

11.1 Global CAR T-cell Therapy Drug Market Size Forecast
11.2 Global CAR T-cell Therapy Drug Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe CAR T-cell Therapy Drug Market Size Forecast by Country
  11.2.3 Asia Pacific CAR T-cell Therapy Drug Market Size Forecast by Region
  11.2.4 South America CAR T-cell Therapy Drug Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Consumption of CAR T-cell Therapy Drug by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)

12.1 Global CAR T-cell Therapy Drug Market Forecast by Type (2025-2032)
  12.1.1 Global Forecasted Sales of CAR T-cell Therapy Drug by Type (2025-2032)
  12.1.2 Global CAR T-cell Therapy Drug Market Size Forecast by Type (2025-2032)
  12.1.3 Global Forecasted Price of CAR T-cell Therapy Drug by Type (2025-2032)
12.2 Global CAR T-cell Therapy Drug Market Forecast by Application (2025-2032)
  12.2.1 Global CAR T-cell Therapy Drug Sales (K MT) Forecast by Application
  12.2.2 Global CAR T-cell Therapy Drug Market Size (M USD) Forecast by Application (2025-2032)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. CAR T-cell Therapy Drug Market Size Comparison by Region (M USD)
Table 5. Global CAR T-cell Therapy Drug Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global CAR T-cell Therapy Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global CAR T-cell Therapy Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global CAR T-cell Therapy Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-cell Therapy Drug as of 2022)
Table 10. Global Market CAR T-cell Therapy Drug Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers CAR T-cell Therapy Drug Sales Sites and Area Served
Table 12. Manufacturers CAR T-cell Therapy Drug Product Type
Table 13. Global CAR T-cell Therapy Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of CAR T-cell Therapy Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. CAR T-cell Therapy Drug Market Challenges
Table 22. Global CAR T-cell Therapy Drug Sales by Type (K MT)
Table 23. Global CAR T-cell Therapy Drug Market Size by Type (M USD)
Table 24. Global CAR T-cell Therapy Drug Sales (K MT) by Type (2019-2024)
Table 25. Global CAR T-cell Therapy Drug Sales Market Share by Type (2019-2024)
Table 26. Global CAR T-cell Therapy Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global CAR T-cell Therapy Drug Market Size Share by Type (2019-2024)
Table 28. Global CAR T-cell Therapy Drug Price (USD/MT) by Type (2019-2024)
Table 29. Global CAR T-cell Therapy Drug Sales (K MT) by Application
Table 30. Global CAR T-cell Therapy Drug Market Size by Application
Table 31. Global CAR T-cell Therapy Drug Sales by Application (2019-2024) & (K MT)
Table 32. Global CAR T-cell Therapy Drug Sales Market Share by Application (2019-2024)
Table 33. Global CAR T-cell Therapy Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global CAR T-cell Therapy Drug Market Share by Application (2019-2024)
Table 35. Global CAR T-cell Therapy Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global CAR T-cell Therapy Drug Sales by Region (2019-2024) & (K MT)
Table 37. Global CAR T-cell Therapy Drug Sales Market Share by Region (2019-2024)
Table 38. North America CAR T-cell Therapy Drug Sales by Country (2019-2024) & (K MT)
Table 39. Europe CAR T-cell Therapy Drug Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific CAR T-cell Therapy Drug Sales by Region (2019-2024) & (K MT)
Table 41. South America CAR T-cell Therapy Drug Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa CAR T-cell Therapy Drug Sales by Region (2019-2024) & (K MT)
Table 43. Global CAR T-cell Therapy Drug Production (K MT) by Region (2019-2024)
Table 44. Global CAR T-cell Therapy Drug Revenue (US$ Million) by Region (2019-2024)
Table 45. Global CAR T-cell Therapy Drug Revenue Market Share by Region (2019-2024)
Table 46. Global CAR T-cell Therapy Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America CAR T-cell Therapy Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe CAR T-cell Therapy Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan CAR T-cell Therapy Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China CAR T-cell Therapy Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Novartis CAR T-cell Therapy Drug Basic Information
Table 52. Novartis CAR T-cell Therapy Drug Product Overview
Table 53. Novartis CAR T-cell Therapy Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Novartis Business Overview
Table 55. Novartis CAR T-cell Therapy Drug SWOT Analysis
Table 56. Novartis Recent Developments
Table 57. Gilead Sciences CAR T-cell Therapy Drug Basic Information
Table 58. Gilead Sciences CAR T-cell Therapy Drug Product Overview
Table 59. Gilead Sciences CAR T-cell Therapy Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Gilead Sciences Business Overview
Table 61. Gilead Sciences CAR T-cell Therapy Drug SWOT Analysis
Table 62. Gilead Sciences Recent Developments
Table 63. Bristol-Myers Squibb CAR T-cell Therapy Drug Basic Information
Table 64. Bristol-Myers Squibb CAR T-cell Therapy Drug Product Overview
Table 65. Bristol-Myers Squibb CAR T-cell Therapy Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Bristol-Myers Squibb CAR T-cell Therapy Drug SWOT Analysis
Table 67. Bristol-Myers Squibb Business Overview
Table 68. Bristol-Myers Squibb Recent Developments
Table 69. J and J CAR T-cell Therapy Drug Basic Information
Table 70. J and J CAR T-cell Therapy Drug Product Overview
Table 71. J and J CAR T-cell Therapy Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. J and J Business Overview
Table 73. J and J Recent Developments
Table 74. JW Therapeutics CAR T-cell Therapy Drug Basic Information
Table 75. JW Therapeutics CAR T-cell Therapy Drug Product Overview
Table 76. JW Therapeutics CAR T-cell Therapy Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. JW Therapeutics Business Overview
Table 78. JW Therapeutics Recent Developments
Table 79. FOSUNKite CAR T-cell Therapy Drug Basic Information
Table 80. FOSUNKite CAR T-cell Therapy Drug Product Overview
Table 81. FOSUNKite CAR T-cell Therapy Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. FOSUNKite Business Overview
Table 83. FOSUNKite Recent Developments
Table 84. Global CAR T-cell Therapy Drug Sales Forecast by Region (2025-2032) & (K MT)
Table 85. Global CAR T-cell Therapy Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 86. North America CAR T-cell Therapy Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 87. North America CAR T-cell Therapy Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 88. Europe CAR T-cell Therapy Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 89. Europe CAR T-cell Therapy Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 90. Asia Pacific CAR T-cell Therapy Drug Sales Forecast by Region (2025-2032) & (K MT)
Table 91. Asia Pacific CAR T-cell Therapy Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 92. South America CAR T-cell Therapy Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 93. South America CAR T-cell Therapy Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 94. Middle East and Africa CAR T-cell Therapy Drug Consumption Forecast by Country (2025-2032) & (Units)
Table 95. Middle East and Africa CAR T-cell Therapy Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 96. Global CAR T-cell Therapy Drug Sales Forecast by Type (2025-2032) & (K MT)
Table 97. Global CAR T-cell Therapy Drug Market Size Forecast by Type (2025-2032) & (M USD)
Table 98. Global CAR T-cell Therapy Drug Price Forecast by Type (2025-2032) & (USD/MT)
Table 99. Global CAR T-cell Therapy Drug Sales (K MT) Forecast by Application (2025-2032)
Table 100. Global CAR T-cell Therapy Drug Market Size Forecast by Application (2025-2032) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of CAR T-cell Therapy Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global CAR T-cell Therapy Drug Market Size (M USD), 2019-2032
Figure 5. Global CAR T-cell Therapy Drug Market Size (M USD) (2019-2032)
Figure 6. Global CAR T-cell Therapy Drug Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. CAR T-cell Therapy Drug Market Size by Country (M USD)
Figure 11. CAR T-cell Therapy Drug Sales Share by Manufacturers in 2023
Figure 12. Global CAR T-cell Therapy Drug Revenue Share by Manufacturers in 2023
Figure 13. CAR T-cell Therapy Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market CAR T-cell Therapy Drug Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by CAR T-cell Therapy Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global CAR T-cell Therapy Drug Market Share by Type
Figure 18. Sales Market Share of CAR T-cell Therapy Drug by Type (2019-2024)
Figure 19. Sales Market Share of CAR T-cell Therapy Drug by Type in 2023
Figure 20. Market Size Share of CAR T-cell Therapy Drug by Type (2019-2024)
Figure 21. Market Size Market Share of CAR T-cell Therapy Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global CAR T-cell Therapy Drug Market Share by Application
Figure 24. Global CAR T-cell Therapy Drug Sales Market Share by Application (2019-2024)
Figure 25. Global CAR T-cell Therapy Drug Sales Market Share by Application in 2023
Figure 26. Global CAR T-cell Therapy Drug Market Share by Application (2019-2024)
Figure 27. Global CAR T-cell Therapy Drug Market Share by Application in 2023
Figure 28. Global CAR T-cell Therapy Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global CAR T-cell Therapy Drug Sales Market Share by Region (2019-2024)
Figure 30. North America CAR T-cell Therapy Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America CAR T-cell Therapy Drug Sales Market Share by Country in 2023
Figure 32. U.S. CAR T-cell Therapy Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada CAR T-cell Therapy Drug Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico CAR T-cell Therapy Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe CAR T-cell Therapy Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe CAR T-cell Therapy Drug Sales Market Share by Country in 2023
Figure 37. Germany CAR T-cell Therapy Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France CAR T-cell Therapy Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. CAR T-cell Therapy Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy CAR T-cell Therapy Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia CAR T-cell Therapy Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific CAR T-cell Therapy Drug Sales and Growth Rate (K MT)
Figure 43. Asia Pacific CAR T-cell Therapy Drug Sales Market Share by Region in 2023
Figure 44. China CAR T-cell Therapy Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan CAR T-cell Therapy Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea CAR T-cell Therapy Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India CAR T-cell Therapy Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia CAR T-cell Therapy Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America CAR T-cell Therapy Drug Sales and Growth Rate (K MT)
Figure 50. South America CAR T-cell Therapy Drug Sales Market Share by Country in 2023
Figure 51. Brazil CAR T-cell Therapy Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina CAR T-cell Therapy Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia CAR T-cell Therapy Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa CAR T-cell Therapy Drug Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa CAR T-cell Therapy Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia CAR T-cell Therapy Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE CAR T-cell Therapy Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt CAR T-cell Therapy Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria CAR T-cell Therapy Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa CAR T-cell Therapy Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global CAR T-cell Therapy Drug Production Market Share by Region (2019-2024)
Figure 62. North America CAR T-cell Therapy Drug Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe CAR T-cell Therapy Drug Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan CAR T-cell Therapy Drug Production (K MT) Growth Rate (2019-2024)
Figure 65. China CAR T-cell Therapy Drug Production (K MT) Growth Rate (2019-2024)
Figure 66. Global CAR T-cell Therapy Drug Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global CAR T-cell Therapy Drug Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global CAR T-cell Therapy Drug Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global CAR T-cell Therapy Drug Market Share Forecast by Type (2025-2032)
Figure 70. Global CAR T-cell Therapy Drug Sales Forecast by Application (2025-2032)
Figure 71. Global CAR T-cell Therapy Drug Market Share Forecast by Application (2025-2032)